Literature DB >> 3991726

Amplification of N-myc sequences in primary human neuroblastomas: correlation with advanced disease stage.

G M Brodeur, R C Seeger, M Schwab, H E Varmus, J M Bishop.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3991726

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  14 in total

1.  Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma.

Authors:  Karin Melanie Cabanillas Stanchi; Gernot Bruchelt; Rupert Handgretinger; Ursula Holzer
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

2.  N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.

Authors:  Michael B Armstrong; Rajen J Mody; D Christian Ellis; Adam B Hill; David A Erichsen; Daniel S Wechsler
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.

Authors:  Louis Chesler; Chris Schlieve; David D Goldenberg; Anna Kenney; Grace Kim; Alex McMillan; Katherine K Matthay; David Rowitch; William A Weiss
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

Review 4.  The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development.

Authors:  Mayumi Higashi; Kohei Sakai; Shigehisa Fumino; Shigeyoshi Aoi; Taizo Furukawa; Tatsuro Tajiri
Journal:  Surg Today       Date:  2019-03-08       Impact factor: 2.549

5.  Microgravity assay of neuroblastoma: in vitro aggregation kinetics and organoid morphology correlate with MYCN expression.

Authors:  Robert A Redden; Edward J Doolin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-03-08       Impact factor: 2.416

6.  ALK expression, prognostic significance, and its association with MYCN expression in MYCN non-amplified neuroblastoma.

Authors:  Dinesh Babu Somasundaram; Sheeja Aravindan; Nandita Gupta; Zhongxin Yu; Ashley Baker; Natarajan Aravindan
Journal:  World J Pediatr       Date:  2022-02-07       Impact factor: 2.764

7.  Chemotherapy-induced apoptosis in a transgenic model of neuroblastoma proceeds through p53 induction.

Authors:  Louis Chesler; David D Goldenberg; Rodney Collins; Matt Grimmer; Grace E Kim; Tarik Tihan; Kim Nguyen; Slava Yakovenko; Katherine K Matthay; William A Weiss
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

8.  Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.

Authors:  Jana Schmitt; Andreas Keller; Nasenien Nourkami-Tutdibi; Sabrina Heisel; Nunja Habel; Petra Leidinger; Nicole Ludwig; Manfred Gessler; Norbert Graf; Frank Berthold; Hans-Peter Lenhof; Eckart Meese
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

Review 9.  Cancer gene discovery in mouse and man.

Authors:  Jenny Mattison; Louise van der Weyden; Tim Hubbard; David J Adams
Journal:  Biochim Biophys Acta       Date:  2009-03-12

10.  Copy number gain of MYCN gene is a recurrent genetic aberration and favorable prognostic factor in Chinese pediatric neuroblastoma patients.

Authors:  Miao Wang; Chunju Zhou; Rongqin Cai; Yong Li; Liping Gong
Journal:  Diagn Pathol       Date:  2013-01-15       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.